Retraction notice to “SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma” [iScience 26 (2023) 106994]
- DOI
- 10.1016/j.isci.2026.117591
- Published
- 2026-10
- Container
- iScience
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.isci.2026.117591,
title = {Retraction notice to “SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma” [iScience 26 (2023) 106994]},
author = {Shanshan Wang and Xin You and Xiaoshu Liu and Fengwei Zhang and Hongjuan Zhou and Xuechai Shang and Long Cai},
year = {2026},
journal = {iScience},
doi = {10.1016/j.isci.2026.117591},
url = {https://doi.org/10.1016/j.isci.2026.117591}
}RIS
TY - JOUR TI - Retraction notice to “SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma” [iScience 26 (2023) 106994] AU - Shanshan Wang AU - Xin You AU - Xiaoshu Liu AU - Fengwei Zhang AU - Hongjuan Zhou AU - Xuechai Shang AU - Long Cai PY - 2026 JO - iScience DO - 10.1016/j.isci.2026.117591 UR - https://doi.org/10.1016/j.isci.2026.117591 ER -
APA
Wang, S., You, X., Liu, X., Zhang, F., Zhou, H., Shang, X., & Cai, L. (2026). Retraction notice to “SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma” [iScience 26 (2023) 106994]. iScience. https://doi.org/10.1016/j.isci.2026.117591
Source records
- crossref · retrieved 2026-11-07T15:55:44.984Z